These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 16428085

  • 1. Angiogenic and proliferative effects of the cytokine VEGF in Ehrlich ascites tumor cells is inhibited by Glycyrrhiza glabra.
    Sheela ML, Ramakrishna MK, Salimath BP.
    Int Immunopharmacol; 2006 Mar; 6(3):494-8. PubMed ID: 16428085
    [Abstract] [Full Text] [Related]

  • 2. Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1alpha in Ehrlich ascites tumor cells.
    Kumar A, D'Souza SS, Nagaraj SR, Gaonkar SL, Salimath BP, Rai KM.
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1221-33. PubMed ID: 19370348
    [Abstract] [Full Text] [Related]

  • 3. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH, Lee SH, Ahn EM, Lee YM.
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [Abstract] [Full Text] [Related]

  • 4. Butyrate-induced proapoptotic and antiangiogenic pathways in EAT cells require activation of CAD and downregulation of VEGF.
    Belakavadi M, Prabhakar BT, Salimath BP.
    Biochem Biophys Res Commun; 2005 Oct 07; 335(4):993-1001. PubMed ID: 16105646
    [Abstract] [Full Text] [Related]

  • 5. Octacosanol isolated from Tinospora cordifolia downregulates VEGF gene expression by inhibiting nuclear translocation of NF-<kappa>B and its DNA binding activity.
    Thippeswamy G, Sheela ML, Salimath BP.
    Eur J Pharmacol; 2008 Jul 07; 588(2-3):141-50. PubMed ID: 18513715
    [Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor immunoneutralization in combination with cisplatin reduces EAC tumor growth.
    Ghosh S, Maity P.
    Int Immunopharmacol; 2006 Oct 07; 6(10):1550-9. PubMed ID: 16919827
    [Abstract] [Full Text] [Related]

  • 7. Antiangiogenic and proapoptotic activities of allyl isothiocyanate inhibit ascites tumor growth in vivo.
    Kumar A, D'Souza SS, Tickoo S, Salimath BP, Singh HB.
    Integr Cancer Ther; 2009 Mar 07; 8(1):75-87. PubMed ID: 19223371
    [Abstract] [Full Text] [Related]

  • 8. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice.
    Pourgholami MH, Yan Cai Z, Lu Y, Wang L, Morris DL.
    Clin Cancer Res; 2006 Mar 15; 12(6):1928-35. PubMed ID: 16551879
    [Abstract] [Full Text] [Related]

  • 9. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW, Kim SJ, Choi HJ, Kim KJ, Kim MJ, Kim SH, Lee HJ, Ko JH, Lee YC, Suzuki A, Kim CH.
    Glycobiology; 2009 Mar 15; 19(3):229-39. PubMed ID: 18974200
    [Abstract] [Full Text] [Related]

  • 10. Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: In vitro and in vivo.
    Hsu SC, Ou CC, Chuang TC, Li JW, Lee YJ, Wang V, Liu JY, Chen CS, Lin SC, Kao MC.
    Cancer Lett; 2009 Aug 18; 281(1):108-16. PubMed ID: 19332363
    [Abstract] [Full Text] [Related]

  • 11. Anti-angiogenic potential of Gleditsia sinensis fruit extract.
    Chow LM, Chui CH, Tang JC, Lau FY, Yau MY, Cheng GY, Wong RS, Lai PB, Leung TW, Teo IT, Cheung F, Guo D, Chan AS.
    Int J Mol Med; 2003 Aug 18; 12(2):269-73. PubMed ID: 12851730
    [Abstract] [Full Text] [Related]

  • 12. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C, Zieher H, Roth A, Hauser K, Lipson KE, Weber KJ, Debus J, Abdollahi A, Huber PE.
    Clin Cancer Res; 2008 Apr 01; 14(7):2210-9. PubMed ID: 18381963
    [Abstract] [Full Text] [Related]

  • 13. Effect of Tinospora cordifolia on the cytokine profile of angiogenesis-induced animals.
    Leyon PV, Kuttan G.
    Int Immunopharmacol; 2004 Dec 15; 4(13):1569-75. PubMed ID: 15454110
    [Abstract] [Full Text] [Related]

  • 14. Paracrine action of sFLT-1 secreted by stably-transfected Ehrlich ascites tumor cells and therapy using sFLT-1 inhibits ascites tumor growth in vivo.
    Ramachandra S, D'Souza SS, Gururaj AE, Shaila MS, Salimath BP.
    J Gene Med; 2009 May 15; 11(5):422-34. PubMed ID: 19266483
    [Abstract] [Full Text] [Related]

  • 15. Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells.
    Hoffmann S, Rockenstein A, Ramaswamy A, Celik I, Wunderlich A, Lingelbach S, Hofbauer LC, Zielke A.
    Mol Cell Endocrinol; 2007 Jan 29; 264(1-2):74-81. PubMed ID: 17101211
    [Abstract] [Full Text] [Related]

  • 16. Antiangiogenic activity of a concentrated effective microorganism fermentation extract.
    Chui CH, Gambari R, Lau FY, Hau DK, Wong RS, Cheng GY, Kok SH, Higa T, Ke B, Chan AS, Fong DW, Tang JC.
    Int J Mol Med; 2006 Nov 29; 18(5):975-9. PubMed ID: 17016630
    [Abstract] [Full Text] [Related]

  • 17. Activation of rapid signaling pathways and the subsequent transcriptional regulation for the proliferation of breast cancer MCF-7 cells by the treatment with an extract of Glycyrrhiza glabra root.
    Dong S, Inoue A, Zhu Y, Tanji M, Kiyama R.
    Food Chem Toxicol; 2007 Dec 29; 45(12):2470-8. PubMed ID: 17664038
    [Abstract] [Full Text] [Related]

  • 18. Piper longum inhibits VEGF and proinflammatory cytokines and tumor-induced angiogenesis in C57BL/6 mice.
    Sunila ES, Kuttan G.
    Int Immunopharmacol; 2006 May 29; 6(5):733-41. PubMed ID: 16546703
    [Abstract] [Full Text] [Related]

  • 19. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY.
    Life Sci; 2006 Nov 17; 79(25):2370-81. PubMed ID: 16959272
    [Abstract] [Full Text] [Related]

  • 20. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
    Lane HA, Wood JM, McSheehy PM, Allegrini PR, Boulay A, Brueggen J, Littlewood-Evans A, Maira SM, Martiny-Baron G, Schnell CR, Sini P, O'Reilly T.
    Clin Cancer Res; 2009 Mar 01; 15(5):1612-22. PubMed ID: 19223496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.